Immediate implant placement in molar extraction sockets using fully tapered tissue level implants: a randomized controlled post-market multinational clinical study - Immediate implant placement using fully tapered tissue level implants

Institut Straumann AG0 个研究点目标入组 144 人开始时间: 2021年12月1日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•Patients must have voluntarily signed the informed consent form before any study related procedures
•- Patients must be a minimum of 18 years of age
•- Periodontally healthy patients (no PPD greater than 4 mm except failing molar or PPD at implants higher than 6 mm)
•- Patients who are in need of a molar extraction (failing tooth) of the maxilla or mandible and replacement with a dental implant
•- Planned site for implant must have a natural tooth or implant mesially or distally in the adjacent tooth positions
•- Patients must have an opposing tooth (natural teeth or implant, fixed or removable restorations) to the planned site
•- Patients must be committed to the study and the required follow-up visits

•- Patients with a systemic disease that would preclude dental implant surgery
•- Patients with any contraindications for oral surgical procedures
•- Patients with mucosal diseases (e.g., erosive lichen planus) in the localized area around the study implant site
•- Patients with a history of local irradiation therapy in the head/neck area
•- Patients with any untreated endodontic lesions or untreated periodontal disease adjacent to the implant site
•- Patients receiving, or having a history of receiving, intravenous or subcutaneous antiresorptive agents, such as bisphosphonates
•- Patients with inadequate oral hygiene (PI higher than 30%) or who are unmotivated for adequate oral hygiene
•- Patients who have physical or mental handicaps that would interfere with the ability to perform adequate oral hygiene
•- Patients who are pregnant or intending to become pregnant during the duration of the study
•- Patients who are heavy smokers (defined as >10 cigarettes per day or >1 cigar per day) or chew/dip tobacco
•- Patients with confirmed alcoholism or known drug abuse (as per medical records)
•- Patients who have undergone administration of any investigational device within 30 days of enrolment in the study
•- Patients with conditions or circumstances, in the opinion of the investigator, which would prevent completion of study participation or interfere with analysis of study results, such as history of non-compliance or unreliability

发起方